Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.8M Buy
167,825
+3,261
+2% +$1.12M 0.81% 33
2026
Q1
$57.9M Buy
164,564
+9,665
+6% +$3.45M 0.84% 33
2025
Q4
$50.7M Buy
154,899
+5,985
+4% +$1.9M 0.72% 36
2025
Q3
$42M Sell
148,914
-1,014
-0.7% -$294K 0.6% 44
2025
Q2
$41.9M Sell
149,928
-68,082
-31% -$19.3M 0.66% 43
2025
Q1
$67.9M Buy
218,010
+11,611
+6% +$3.43M 1.19% 27
2024
Q4
$53.8M Buy
206,399
+7,219
+4% +$2.14M 0.91% 33
2024
Q3
$64.2M Sell
199,180
-2,933
-1% -$959K 1.1% 29
2024
Q2
$63.2M Buy
202,113
+29,602
+17% +$8.7M 1.15% 32
2024
Q1
$49M Buy
172,511
+31,081
+22% +$9.09M 0.91% 39
2023
Q4
$40.7M Buy
141,430
+15,388
+12% +$4.19M 0.84% 39
2023
Q3
$33.9M Buy
126,042
+2,619
+2% +$654K 0.79% 42
2023
Q2
$27.4M Buy
123,423
+3,911
+3% +$908K 0.62% 51
2023
Q1
$28.9M Buy
119,512
+5,751
+5% +$1.41M 0.69% 47
2022
Q4
$29.9M Sell
113,761
-13,974
-11% -$3.75M 0.74% 44
2022
Q3
$28.8M Buy
127,735
+8,921
+8% +$2.16M 0.79% 41
2022
Q2
$28.9M Buy
118,814
+3,047
+3% +$747K 0.74% 44
2022
Q1
$28M Buy
115,767
+6,634
+6% +$1.52M 0.64% 50
2021
Q4
$24.6M Sell
109,133
-153,286
-58% -$32.4M 0.53% 53
2021
Q3
$55.8M Sell
262,419
-28,749
-10% -$6.62M 1.36% 26
2021
Q2
$71M Buy
291,168
+19,135
+7% +$4.71M 1.73% 12
2021
Q1
$67.7M Buy
272,033
+4,834
+2% +$1.15M 1.8% 10
2020
Q4
$61.4M Buy
267,199
+1,840
+0.7% +$424K 1.7% 11
2020
Q3
$67.4M Buy
265,359
+4,799
+2% +$1.19M 2.08% 6
2020
Q2
$61.5M Buy
260,560
+2,631
+1% +$600K 2.06% 7
2020
Q1
$52.3M Buy
257,929
+9,783
+4% +$2.14M 2.05% 8
2019
Q4
$59.8M Buy
248,146
+4,704
+2% +$1.04M 1.92% 9
2019
Q3
$47.1M Buy
243,442
+7,418
+3% +$1.42M 1.66% 16
2019
Q2
$43.5M Buy
236,024
+1,803
+0.8% +$323K 1.56% 18
2019
Q1
$44.5M Buy
234,221
+230,595
+6,359% +$44M 1.7% 16
2018
Q4
$706K Sell
3,626
-158,116
-98% -$30.8M 2.07% 14
2018
Q3
$33.5M Buy
+161,742
New +$31.9M 1.5% 21
2018
Q2
Sell
-211,760
Closed -$36.1M 351
2018
Q1
$36.1M Buy
211,760
+19,215
+10% +$3.53M 1.49% 21
2017
Q4
$33.5M Buy
192,545
+8,539
+5% +$1.51M 1.35% 24
2017
Q3
$34.3M Buy
184,006
+8,513
+5% +$1.51M 1.48% 17
2017
Q2
$30.2M Buy
175,493
+34,994
+25% +$5.69M 1.36% 20
2017
Q1
$23.1M Buy
140,499
+133,036
+1,783% +$22.1M 1.05% 34
2016
Q4
$1.09M Buy
7,463
+1,060
+17% +$160K 0.05% 177
2016
Q3
$1.07M Buy
6,403
+152
+2% +$25.7K 0.05% 177
2016
Q2
$951K Buy
6,251
+355
+6% +$55.2K 0.05% 179
2016
Q1
$884K Buy
5,896
+594
+11% +$88.2K 0.05% 181
2015
Q4
$860K Buy
5,302
+34
+0.6% +$5.34K 0.04% 188
2015
Q3
$729K Hold
5,268
0.04% 190
2015
Q2
$809K Sell
5,268
-5
-0.1% -$801 0.04% 188
2015
Q1
$843K Hold
5,273
0.04% 185
2014
Q4
$840K Sell
5,273
-14
-0.3% -$2.18K 0.04% 186
2014
Q3
$743K Buy
5,287
+5
+0.1% +$653 0.04% 189
2014
Q2
$625K Sell
5,282
-176
-3% -$20.4K 0.03% 203
2014
Q1
$673K Sell
5,458
-133
-2% -$16.1K 0.04% 190
2013
Q4
$638K Sell
5,591
-134
-2% -$15.2K 0.03% 191
2013
Q3
$641K Buy
5,725
+11
+0.2% +$1.19K 0.04% 194
2013
Q2
$564K Buy
+5,714
New +$593K 0.03% 195

Other funds holding AMGN

HM Payson & Co's AMGN Position: Q2 2026 in Review

HM Payson & Co increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $1.12M and bringing the position to 167,825 shares worth $60.8M. The position accounts for 0.81% of the portfolio, ranked #33.

HM Payson & Co first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $71M in Q2 2021. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HM Payson & Co held 167,825 shares of Amgen worth $60.8M as of Q2 2026.
  • HM Payson & Co bought 3,261 Amgen shares in Q2 2026, an estimated $1.12M.
  • Amgen made up 0.81% of HM Payson & Co's portfolio in Q2 2026, its #33 holding.
  • HM Payson & Co first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • HM Payson & Co's Amgen position peaked at $71M in Q2 2021.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.